Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple Dose Study of Delpazolid (LCB01-0371) in Healthy Males
NCT02540460Phase 1Completed
- Sponsor
- LigaChem Biosciences
- Start
- Jun 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of delpazolid in Tuberculosis (TB) (4 arms), sponsored by LigaChem Biosciences. Primary endpoint: Number of Adverse Events. Started Jun 2014; status: completed.
02
Drugs
delpazolid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02540460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02540460.